SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Curocell Seeks Approval to Amend Phase 3 Lymphoma Trial Plan

Curocell applied to South Korea's Ministry of Food and Drug Safety for approval to amend its Phase 3 lymphoma trial plan.

Related stories